Searched for
STERILE FILL FINISH
Piramal Pharma Q2 Results: Net profit jumps over 4-fold to Rs 23 cr; revenue at Rs 2,242 crPiramal Pharma reported a significant increase in consolidated net profit for Q2, growing from Rs 5 crore last year to Rs 23 crore. Revenue...
India is a significant market for aseptic packaging: SIG’s Samuel SigristSwiss packaging provider SIG Combibloc aims to cater India’s growing milk market as well the demand for sustainable packaging.
US co Amneal plans units in India for weight-loss drugsAmneal Pharmaceuticals is set to invest $150-200 million over four to five years to build a manufacturing facility in Ahmedabad for weight ...
Amneal Pharmaceuticals to invest up to USD 200 mn in India to set up 2 new plantsAmneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds wil...
USFDA pulls up Eugia for manufacturing lapses, data accuracy at Hyderabad plantThe US Food and Drug Administration (USFDA) has issued a warning letter to Eugia Pharma Specialities, a subsidiary of Aurobindo Pharma, cit...
USFDA pulls up Sun Pharma for lapses in Halol plant"This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceutica...
Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...
Wockhardt unit partners with SII subsidiary to set up vaccine manufacturing plant in UKThe collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities al...
Wockhardt, Serum enter pact to do fill-finish of vaccinesWockhardt UK has manufactured a COVID-19 vaccine in collaboration with UK Government and AstraZeneca. Its collaboration with Serum Life Sci...
Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
Seeing good demand for biologics manufacturing: Syngene CEO Jonathan HuntIn an interview to ET, Jonathan Hunt, CEO and MD of Syngene said the company has spare capacity and is also investing on expansion of micro...
Cipla to tap foreign cos for large-scale vax playMoving beyond a wide portfolio of Covid drugs and diagnostic kits, the Mumbai-based company — with revenues of nearly Rs 20,000 crore — now...
15 million doses discarded: The company at the heart of J&J vaccine row had history of violationsJ&J locked arms with Emergent in April 2020, enlisting the lesser-known company to manufacture its vaccine. At the time, Emergent's Bayview...
Wockhardt snags Covid-19 vaccine manufacturing deal from the UK govtThis deal by Wockhardt entails only manufacturing the vaccine only for the United Kingdom. The government has reserved one fill and finish ...
The jewel of the Indian pharma crown has lost its shine: Amit Ranjan on Sun PharmaSun Pharma got two inspections – one for Mohali and one for Halol sight – and if you summarise, I am sorry to say that the jewel of the Ind...
Mylan gets warning letter from USFDA for lapses at 3 unitsUSFDA has issued a warning letter to Mylan Laboratories for violation of current good manufacturing practice norms at its three plants in K...
- 'Practice' for the next level
Adopting best practices can help SMEs gain the required market edge. This article explores the concept of best practices in the context of ...